StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$0.29−0.08 (-20.99%)

Close on Nov 20, 2026Market cap $12.23MP/E –Yield –

MIRA Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MIRA Pharmaceuticals's price to book ratio was 3.2× on Nov 11, 2026, against 7.7× a year earlier. Over the last 3 years it ranged from 1.3× to 52.3×, with a median of 5.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.2×−4.7
2025Dec 31, 20257.9×+4.0
2024Dec 31, 20243.9×+2.5
2023Dec 29, 20231.4×–

More MIRA Pharmaceuticals figures

See a number that looks wrong?